Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The role of CD36 in cardiovascular diseases

View through CrossRef
CD36, also known as scavenger receptor B2, is a multifunctional receptor widely expressed in various organs. CD36 plays a crucial role in the uptake of long-chain fatty acids, the main metabolic substrate in myocardial tissue. The maturation and transportation of CD36 was regulated by the post-translational modifications including phosphorylation, ubiquitination, glycosylation, and palmitoylation. CD36 is decreased in pathological cardiac hypertrophy caused by ischemia-reperfusion and pressure overload, while increased in diabetic cardiomyopathy. Deficiency of CD36 alleviate diabetic cardiomyopathy, while overexpression of CD36 eliminates the damage of ischemia-reperfusion, suggesting that CD36 is closely associated with the progression of cardiovascular diseases. and it is expected to be a new therapeutic target. This review summarizes the regulation and post-translational modifications of CD36, and evaluates its role in main cardiovascular diseases and its potential as a therapeutic target.
Title: The role of CD36 in cardiovascular diseases
Description:
CD36, also known as scavenger receptor B2, is a multifunctional receptor widely expressed in various organs.
CD36 plays a crucial role in the uptake of long-chain fatty acids, the main metabolic substrate in myocardial tissue.
The maturation and transportation of CD36 was regulated by the post-translational modifications including phosphorylation, ubiquitination, glycosylation, and palmitoylation.
CD36 is decreased in pathological cardiac hypertrophy caused by ischemia-reperfusion and pressure overload, while increased in diabetic cardiomyopathy.
Deficiency of CD36 alleviate diabetic cardiomyopathy, while overexpression of CD36 eliminates the damage of ischemia-reperfusion, suggesting that CD36 is closely associated with the progression of cardiovascular diseases.
and it is expected to be a new therapeutic target.
This review summarizes the regulation and post-translational modifications of CD36, and evaluates its role in main cardiovascular diseases and its potential as a therapeutic target.

Related Results

Foamy Monocytes Form Early and Contribute to Nascent Atherosclerosis in Mice With Hypercholesterolemia
Foamy Monocytes Form Early and Contribute to Nascent Atherosclerosis in Mice With Hypercholesterolemia
Objective— To examine infiltration of blood foamy monocytes, containing intracellular lipid droplets, into early atherosclerotic lesions and its contribution to develop...
TRPM2 deficiency protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages
TRPM2 deficiency protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages
ABSTRACT Atherosclerosis is the major cause of ischemic heart diseases and ischemic brain stroke, which are the leading causes of mortality world...
Posttransfusion purpura‐like syndrome associated with CD36 (Naka) isoimmunization
Posttransfusion purpura‐like syndrome associated with CD36 (Naka) isoimmunization
BACKGROUND: CD36 deficiency, which could lead to CD36 isoimmunization, has been reported in the Japanese population. CD36 isoantibody has been involved in platelet transfusion refr...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...

Back to Top